期刊文献+

中国人群中几种常见的线粒体DNA单倍型帕金森病致病相对危险度研究

Study on relative risk of Parkinson' s disease in Chinese classified common mtDNA haplogroups
下载PDF
导出
摘要 目的研究几种东亚人群中常见的线粒体DNA(mtDNA)单倍型与散发性帕金森病(PD)的关系。方法用酚/氯仿法从79例PD患者和63名健康对照者的外周静脉血中提取基因组DNA,采用限制片段长度多态性(PCR-RFLP)方法对其进行4个东亚人群常见的mtDNA单倍型相关单核苷酸多态性(SNP)位点的检测。结果 PD组检出单倍型A 2例,单倍型C 4例,单倍型D 5例,单倍型G 2例;对照组检出单倍型A 3例,单倍型C 9例,单倍型D 8例,单倍型G 1例。在这4种单倍型中,单倍型G的PD致病相对危险度最高,而单倍型C最低,但差异无统计学意义(P>0.05)。结论在我们研究的4种单倍型中,没有发现PD致病相对优势单倍型,虽然单倍型C致病相对危险度最低,但还需要进一步加大样本量作年龄和性别分层研究来证实它的作用。 Objective To explore the relationship between several common haplogroups and sporadic Parkinson' s disease ( PD ) in Chinese. Methods Extraction of total genomic DNA from venous blood cells of 79 PD patients and 63 healthy controls was performed by hydroxybenzene-chloroform method respectively, the 4 single nucleotide polymorphisms (SNP) which is related to the several common haplogroups were genctyped by PCR-RFLP method. Resuits 2 individuals of haplogroup A, 4 individuals of haplogroup C, 5 individuals of haplogroup D, 2 individuals of haplogroup G were found in the PD patients, and 3 individuals of haplogroup A, 9 individuals of haplogroup C, 8 individuals of haplogroup D, only 1 individuals of haplogroup G were found in the healthy controls. So individuals classified as haplogroup G have the highest relative risk of PD, whereas individuals classified as haplogroup C have the lowest relative risk of PD, but there was no significant difference (P 〉 0. 05 ). Conclusion There was no advantage haplogroup among the fours in our study, while individuals classified as haplogroup C have the lowest relative risk of PD, additional large sample stratified studies of sex and age will be need to confirm the protective effect of the haplogroup.
出处 《中国临床新医学》 2011年第5期416-419,共4页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
基金 广西科学自然基金资助项目(编号:桂科自0832139)
关键词 线粒体DNA 单倍型 帕金森病(PD) Mitochondrial DNA Haplogroup Parkinson' s disease(PD)
  • 相关文献

参考文献9

  • 1Parker WD Jr,Boyson SJ,Parks JK.Abnormalities of the electron transport chain in idiopathic Parkinson's disease[J].Ann Neurol,1989,26(6):719-723.
  • 2Simon DK,Mayeux R,Marder K.Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson's disease[J].Neurology,2000,54(3):703-709.
  • 3van der Walt JM,Nicodemus KK,Martin ER.Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease[J].Am J Hum Genet,2003,72(4):804-811.
  • 4Torroni A,Huoponen K,Francalacci P.Classification of European mtDNA from an analysis of three European poplations[J].Genet Soc Amer,1996,144(4):1835-1850.
  • 5Schapira AH,Cooper JM,Dexter D,et al.Mitochondfial complex I deficiency in Parkinson's disease[J].J Neurochem,1990,54(3):823-827.
  • 6Cann RL,Stoneking M,Wilson AC.Mitochondrial DNA and human evolution[J].Nature,1987,325(6099):31-36.
  • 7Autere J,Moilanen JS,Finnil S,et al.Mitochondrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementia[J].Hum Genet,2004,115(1):29-35.
  • 8Cantuti-castelvetri I,Lin MT,Zheng K,et al.Somatic mitochondrial DNA mutations in single neurons and glia[J].Neurobiol Aging,2005,26(10):1343-1355.
  • 9Schoeler S,Hertel S,Haroon MF,et al.Absence of major accumulation of mitochondrial ND5 mutations in Parkinson patient muscle[J].Clin Neuropathol,2007,26(4):164-168.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部